DR. WENDY DE ROOCK, medische oncologie
0848.223.527 · rovalta.com · 27/09/2026
DR. WENDY DE ROOCK, medische oncologie
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODR. WENDY DE ROOCK, medische oncologie is a Private limited company incorporated in 2012. Its main activity is: Specialist medical practice activities. Its registered office is in Maasmechelen.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0848.223.527
- Incorporation
- 18/08/2012
- Legal form
- Private limited company
- Registered office
- Marie Joséestraat(E) 15
3630 Maasmechelen · FlandreSee on map - Contributed capital
- 14 260,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 320,7 k € | +0.7% | 318,6 k € | +0.6% | 316,7 k € | +17.0% | 270,7 k € | +5.1% | 257,5 k € |
| EBITDA | 320,3 k € | +0.6% | 318,3 k € | +0.6% | 316,2 k € | +17.0% | 270,2 k € | +5.1% | 257,1 k € |
| Operating result | 318,3 k € | +1.0% | 315,3 k € | +0.6% | 313,3 k € | +20.3% | 260,4 k € | +5.3% | 247,2 k € |
| Net result | 233,4 k € | -14.6% | 273,4 k € | +23.8% | 220,8 k € | +17.2% | 188,4 k € | -2.9% | 194 k € |
| Balance sheet | |||||||||
| Equity | 930,3 k € | -24.8% | 1,2 M € | +10.6% | 1,1 M € | +8.5% | 1 M € | +3.4% | 996,5 k € |
| Total assets | 1,3 M € | +2.3% | 1,2 M € | +8.7% | 1,1 M € | +8.2% | 1,1 M € | +4.2% | 1 M € |
| Cash | 356,9 k € | +83.1% | 195 k € | -46.0% | 361 k € | -12.3% | 411,6 k € | -22.9% | 534 k € |
| Debts | 346 k € | +3044% | 11 k € | -63.2% | 29,9 k € | -2.5% | 30,7 k € | +37.1% | 22,4 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
WENDY DE ROOCK | Director |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
WENDY DE ROOCK | Manager |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 21/08/2026 | 24/08/2025 | 31/08/2024 | 19/08/2023 | 25/08/2022 | 21/08/2021 |
| General meeting | 01/06/2026 | 02/06/2025 | 03/06/2024 | 05/06/2023 | 07/06/2022 | 07/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 01/06/2026 | 21/08/2026 | Dutch | |
| Micro model | 31/12/2024 | 02/06/2025 | 24/08/2025 | Dutch | |
| Micro model | 31/12/2023 | 03/06/2024 | 31/08/2024 | Dutch | |
| Micro model | 31/12/2022 | 05/06/2023 | 19/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 07/06/2022 | 25/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 07/06/2021 | 21/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 02/06/2020 | 08/10/2020 | Dutch | |
| Micro model | 31/12/2018 | 03/06/2019 | 17/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 04/06/2018 | 31/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 06/06/2017 | 29/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 06/06/2016 | 29/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 01/06/2015 | 28/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 02/06/2014 | 28/08/2014 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
WENDY DE ROOCK | Director |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
WENDY DE ROOCK | Manager |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025233,4 k €↓
- 2024Annual accounts 2024273,4 k €↑
- 2023Annual accounts 2023220,8 k €↑
- 2022Annual accounts 2022188,4 k €↓
- 2021Annual accounts 2021194 k €↑
- 2020Annual accounts 2020156,1 k €↓
- 2019Annual accounts 2019189,8 k €↑
- 2018Annual accounts 2018154,5 k €↑
- 2017Annual accounts 2017133,5 k €↑
- 2016Annual accounts 2016116,8 k €↑
- 2015Annual accounts 201577,9 k €↑
- 2014Annual accounts 201475,5 k €↑
- 2013Annual accounts 201339,4 k €
- 18/08/2012IncorporationPrivate limited company
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Marie Joséestraat(E) 15, 3630 MaasmechelenCurrent | CBE, tracked since 27/09/2026 | CBE |
| MARIE-JOSÉESTRAAT 15, 3630 Maasmechelen | accounts 2021 → 2025 | Accounts 2025 · 2026-00419592 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DR. WENDY DE ROOCK, medische oncologieCurrent | CBE, tracked since 27/09/2026 | CBE |
| DR. WENDY DE ROOCK | accounts 2021 → 2025 | Accounts 2025 · 2026-00419592 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.